Influenza Vaccine Market Size, Growth, Key Players, Global Industry Trends, Analysis and Forecast to 2027

The Influenza Vaccine Market is expected to reach US$ 9.1 Billion by 2027, exhibiting a CAGR of 7.9% during 2022-2027.

SHERIDAN, WY, USA, February 6, 2023 /EINPresswire.com/ -- According to IMARC Group’s latest report, titled “𝗜𝗻𝗳𝗹𝘂𝗲𝗻𝘇𝗮 𝗩𝗮𝗰𝗰𝗶𝗻𝗲 𝗠𝗮𝗿𝗸𝗲𝘁: 𝗚𝗹𝗼𝗯𝗮𝗹 𝗜𝗻𝗱𝘂𝘀𝘁𝗿𝘆 𝗧𝗿𝗲𝗻𝗱𝘀, 𝗦𝗵𝗮𝗿𝗲, 𝗦𝗶𝘇𝗲, 𝗚𝗿𝗼𝘄𝘁𝗵, 𝗢𝗽𝗽𝗼𝗿𝘁𝘂𝗻𝗶𝘁𝘆 𝗮𝗻𝗱 𝗙𝗼𝗿𝗲𝗰𝗮𝘀𝘁 𝟮𝟬𝟮𝟮-𝟮𝟬𝟮𝟳”, the global influenza vaccine market size reached US$ 5.9 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 9.1 Billion by 2027, exhibiting a CAGR of 7.9% during 2022-2027.

Influenza vaccines protect against four influenza viruses that cause throat, lung, and nose infections. Common symptoms of influenza include head and body aches, cough, fever, and a stuffy or runny nose. These vaccines are formulated using three different influenza viruses, including influenza type A and B with H3N2 and H1N1 virus strains. They are given as an intramuscular (IM) needle injection into the outer and upper arm muscles. These therapeutics are available in inactivated, adjuvant, live attenuated, and recombinant influenza variants. Currently, governments of various nations have mandated immunization against influenza among young children.  

𝗗𝗼𝘄𝗻𝗹𝗼𝗮𝗱 𝗳𝗿𝗲𝗲 𝘀𝗮𝗺𝗽𝗹𝗲 𝗯𝗿𝗼𝗰𝗵𝘂𝗿𝗲: https://www.imarcgroup.com/influenza-vaccine-market/requestsample

𝗜𝗻𝗳𝗹𝘂𝗲𝗻𝘇𝗮 𝗩𝗮𝗰𝗰𝗶𝗻𝗲 𝗠𝗮𝗿𝗸𝗲𝘁 𝗧𝗿𝗲𝗻𝗱𝘀:

Significant funding by regulatory bodies in improving healthcare infrastructure and the implementation of various initiatives to monitor the distribution, administration, and supply of flu vaccines represents one of the key factors primarily boosting the market growth. Moreover, the rising consumer awareness regarding influenza vaccines and the easy product accessibility through immunization programs and camps are providing a considerable thrust to the market growth. Furthermore, the rising geriatric population and growing instances of kidney diseases, metabolic diseases, and chronic neurological and lung disorders are accelerating the market growth. Besides this, increasing investments in research and development (R&D) activities and the surging prevalence of influenza across the globe are creating a positive outlook for the market.

𝗖𝗵𝗲𝗰𝗸𝗼𝘂𝘁 𝗡𝗼𝘄: https://www.imarcgroup.com/checkout?id=4206&method=1

𝗜𝗻𝗳𝗹𝘂𝗲𝗻𝘇𝗮 𝗩𝗮𝗰𝗰𝗶𝗻𝗲 𝗠𝗮𝗿𝗸𝗲𝘁 𝟮𝟬𝟮𝟮-𝟮𝟬𝟮𝟳 𝗖𝗼𝗺𝗽𝗲𝘁𝗶𝘁𝗶𝘃𝗲 𝗔𝗻𝗮𝗹𝘆𝘀𝗶𝘀 𝗮𝗻𝗱 𝗦𝗲𝗴𝗺𝗲𝗻𝘁𝗮𝘁𝗶𝗼𝗻:

𝗖𝗼𝗺𝗽𝗲𝘁𝗶𝘁𝗶𝘃𝗲 𝗟𝗮𝗻𝗱𝘀𝗰𝗮𝗽𝗲 𝗪𝗶𝘁𝗵 𝗞𝗲𝘆 𝗣𝗹𝗮𝘆𝗲𝗿𝘀:

The competitive landscape of the influenza vaccine market has been studied in the report with the detailed profiles of the key players operating in the market.

𝗦𝗼𝗺𝗲 𝗼𝗳 𝘁𝗵𝗲𝘀𝗲 𝗸𝗲𝘆 𝗽𝗹𝗮𝘆𝗲𝗿𝘀 𝗶𝗻𝗰𝗹𝘂𝗱𝗲:

• Abbott Laboratories
• AstraZeneca plc
• CSL Limited
• Daiichi Sankyo Company Limited
• Emergent BioSolutions Inc.
• F. Hoffmann-La Roche AG
• Gamma Vaccines Pty Ltd
• GlaxoSmithKline plc
• Merck & Co. Inc.
• Novartis AG
• Pfizer Inc.
• Sanofi
• SINOVAC

𝗞𝗲𝘆 𝗠𝗮𝗿𝗸𝗲𝘁 𝗦𝗲𝗴𝗺𝗲𝗻𝘁𝗮𝘁𝗶𝗼𝗻:

The report has segmented the influenza vaccine market on the basis of breakup by vaccine type, technology, age group, route of administration and region.

𝗕𝗿𝗲𝗮𝗸𝘂𝗽 𝗯𝘆 𝗩𝗮𝗰𝗰𝗶𝗻𝗲 𝗧𝘆𝗽𝗲:

• Quadrivalent
• Trivalent

𝗕𝗿𝗲𝗮𝗸𝘂𝗽 𝗯𝘆 𝗧𝗲𝗰𝗵𝗻𝗼𝗹𝗼𝗴𝘆:

• Egg-based
• Cell-based

𝗕𝗿𝗲𝗮𝗸𝘂𝗽 𝗯𝘆 𝗔𝗴𝗲 𝗚𝗿𝗼𝘂𝗽:

• Pediatric
• Adult

𝗕𝗿𝗲𝗮𝗸𝘂𝗽 𝗯𝘆 𝗥𝗼𝘂𝘁𝗲 𝗼𝗳 𝗔𝗱𝗺𝗶𝗻𝗶𝘀𝘁𝗿𝗮𝘁𝗶𝗼𝗻:

• Injection
• Nasal Spray

𝗕𝗿𝗲𝗮𝗸𝘂𝗽 𝗯𝘆 𝗥𝗲𝗴𝗶𝗼𝗻:

• North America (United States, Canada)
• Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
• Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa (United Arab Emirates, Saudi Arabia, Turkey, South Africa, Others)

𝗔𝘀𝗸 𝗔𝗻𝗮𝗹𝘆𝘀𝘁 𝗳𝗼𝗿 𝟭𝟬% 𝗳𝗿𝗲𝗲 𝗰𝘂𝘀𝘁𝗼𝗺𝗶𝘇𝗲𝗱 𝗿𝗲𝗽𝗼𝗿𝘁: https://www.imarcgroup.com/request?type=report&id=4206&flag=C

This report can serve as an excellent guide for investors, researchers, consultants, marketing strategists and all those who are planning to foray into the market in any form.

𝗞𝗲𝘆 𝗛𝗶𝗴𝗵𝗹𝗶𝗴𝗵𝘁𝘀 𝗼𝗳 𝘁𝗵𝗲 𝗥𝗲𝗽𝗼𝗿𝘁:

• Market Performance (2016-2021)
• Market Outlook (2022-2027)
• Market Trends
• Market Drivers and Success Factors
• Impact of COVID-19
• Value Chain Analysis
• Comprehensive mapping of the competitive landscape

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

𝗕𝗿𝗼𝘄𝘀𝗲 𝗠𝗼𝗿𝗲 𝗥𝗲𝗹𝗮𝘁𝗲𝗱 𝗥𝗲𝗽𝗼𝗿𝘁𝘀:

Human Growth Hormone Market

Us Generic Drug Market

𝗔𝗯𝗼𝘂𝘁 𝗨𝘀:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.

Elena Anderson
IMARC Services Private Limited
+1 631-791-1145
email us here